ImmunoGen (IMGN) hikes on Takeda deal

Loading...
Loading...
ImmunoGen, Inc.
IMGN
shares gained 16.8% to $8.69 following the announcement of Takeda deal. Share volume was seven million, compared to an all-day average of 1.5 million
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...